Clustering data with hclust algorithm for (Study ST003261)

(Analysis AN005345)
MetaboliteStructureF1F2F3F4F5F6F7F8F9F10F11F12F13F14F15F16F17F18F19F20F21F22
PC 18:1/20:4;O2ME8570872.172.522.040.170.360.310.271.741.862.110.050.120.400.240.292.232.772.650.100.260.350.33
PE 16:0/22:4;OME8570742.462.462.150.030.170.140.082.071.712.370.260.050.880.140.102.392.422.530.040.250.090.07
PC 16:0/22:4;O2*ME8570901.671.761.26NANANANA0.920.830.760.07NA0.14NANA1.561.671.28NA0.07NANA
PI 18:0/20:4;OME8570961.561.711.46NANANANA0.930.801.150.15NA0.53NANA1.221.081.25NA0.17NANA
PI 18:0/22:4;OME8571021.511.591.25NANANANA0.930.801.110.25NA0.75NANA1.171.121.26NA0.27NANA
PI 18:1/20:4;O2ME8571001.952.001.63NANANANA0.620.610.940.02NA0.16NANA1.101.351.26NA0.03NANA
PI 18:1/20:4;O3ME8571012.142.141.84NANANANA0.750.640.780.01NA0.15NANA1.151.241.11NA0.04NANA
PI 16:0/20:4;OME8570942.041.821.64NANANANA0.720.750.980.11NA0.44NANA1.221.061.11NA0.13NANA
PI 16:0/20:4;O3ME8570951.861.911.69NANANANA0.810.620.980.27NA0.46NANA1.021.071.06NA0.25NANA
PI 18:1/20:4;OME8570991.711.921.74NANANANA0.760.681.090.09NA0.31NANA1.201.251.15NA0.10NANA
PI 18:0/22:4;O3*ME8571041.971.761.46NANANANA0.940.810.950.03NA0.43NANA1.191.191.21NA0.05NANA
PI 18:0/22:4;O2*ME8571031.922.001.43NANANANA0.830.721.010.09NA0.28NANA1.181.191.24NA0.11NANA
PI 18:0/20:4;O2ME8570971.911.901.55NANANANA0.840.780.980.05NA0.23NANA1.201.301.20NA0.05NANA
PI 18:0/20:4;O3ME8570981.911.881.58NANANANA0.990.790.940.01NA0.26NANA1.231.191.20NA0.02NANA
PC 16:0/22:4;OME8570891.621.791.750.570.530.540.621.251.071.751.350.421.060.580.481.281.341.730.260.990.520.46
PC 18:0/22:4;OME8570921.181.331.500.240.410.390.291.331.161.972.310.281.390.460.371.351.061.690.171.410.490.43
PC 18:0/20:4;O2ME8570842.552.632.150.460.580.690.481.391.331.350.180.490.540.490.541.811.811.630.330.440.630.56
PC 18:0/20:4;O3ME8570851.892.171.780.810.480.480.582.031.611.570.010.520.420.570.571.821.611.790.320.290.610.67
PE 16:0/20:4;OME8570652.152.051.680.220.860.710.491.331.181.870.200.381.051.020.671.931.981.830.210.270.310.30
PC 16:0/20:4;OME8570801.821.941.750.340.840.610.611.561.211.630.380.450.830.960.751.641.631.550.390.530.590.62
PC 18:0/20:4;OME8570831.941.961.910.360.750.620.581.731.421.520.400.420.820.800.641.781.671.740.390.450.410.43
PC 18:1/20:4;OME8570861.842.011.810.260.680.590.481.821.501.800.450.410.830.750.611.781.661.910.230.480.380.42
PE 18:0/20:4;O3ME8570702.322.011.730.141.761.080.651.511.161.290.030.321.171.340.911.641.511.360.180.160.220.21
PE 18:1/20:4;O3ME8570732.392.331.890.211.691.040.621.270.991.190.020.381.061.190.811.621.541.330.320.200.300.35
PE 18:0/20:4;OME8570681.701.701.540.331.160.820.671.321.111.610.420.541.091.050.881.511.431.520.460.520.500.53
PE 18:1/20:4;OME8570711.541.601.610.321.290.960.701.231.061.520.220.571.131.110.911.401.411.470.490.490.700.68
PE 18:0/20:4;O2ME8570691.671.661.400.431.541.220.901.000.841.260.150.671.011.451.151.281.431.370.520.460.540.59
PE 18:1/20:4;O2ME8570721.611.591.440.491.681.130.810.880.720.990.120.731.201.350.981.361.311.070.750.510.800.77
PC 16:0/20:4;O2ME8570811.521.541.460.590.680.650.621.040.991.200.340.630.881.071.131.381.711.590.430.751.121.07
PC 16:0/20:4;O3ME8570821.781.851.610.801.080.910.711.491.191.300.010.730.650.820.731.561.331.450.570.530.890.83
PC 18:1/20:4;O3ME8570881.891.731.800.940.780.790.781.691.151.150.030.880.570.971.041.461.161.400.530.490.810.90
PE 18:0/22:4;O2*ME8570781.411.251.170.411.981.551.210.760.891.220.130.781.122.081.551.231.521.350.200.300.150.32
PE 18:0/22:4;O3*ME8570791.231.050.830.232.441.771.080.990.820.950.000.601.512.561.551.080.830.980.370.210.350.26
PE 16:0/20:4;O3ME857067NANANA0.112.581.480.82NANANANA0.352.562.081.26NANANA0.200.190.200.17
PE 16:0/22:4;O3*ME857076NANANA0.362.441.530.92NANANANA0.591.841.931.41NANANA0.280.260.220.22
PE 18:0/22:4;OME857077NANANA0.401.350.930.74NANANANA0.771.461.451.14NANANA1.010.970.920.88
PE 16:0/20:4;O2ME857066NANANA1.021.231.080.77NANANANA0.881.201.401.17NANANA0.640.950.840.82
PE 16:0/22:4;O2*ME857075NANANA0.741.301.071.04NANANANA0.731.711.381.40NANANA0.470.890.580.69

Factors:

F1Sample source:Breast cancer cells | Treatment:10 µM Comp. 1 | time point:2 h
F2Sample source:Breast cancer cells | Treatment:10 µM Comp. 2 | time point:2 h
F3Sample source:Breast cancer cells | Treatment:10 µM Comp. 3 | time point:2 h
F4Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:24 h
F5Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:2 h
F6Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:4 h
F7Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:6 h
F8Sample source:Breast cancer cells | Treatment:1 µM Comp. 1 | time point:2 h
F9Sample source:Breast cancer cells | Treatment:1 µM Comp. 2 | time point:2 h
F10Sample source:Breast cancer cells | Treatment:1 µM Comp. 3 | time point:2 h
F11Sample source:Breast cancer cells | Treatment:1 µM RSL3 + 3 µM Ferrostatin | time point:2 h
F12Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:24 h
F13Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:2 h
F14Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:4 h
F15Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:6 h
F16Sample source:Breast cancer cells | Treatment:3 µM Comp. 1 | time point:2 h
F17Sample source:Breast cancer cells | Treatment:3 µM Comp. 2 | time point:2 h
F18Sample source:Breast cancer cells | Treatment:3 µM Comp. 3 | time point:2 h
F19Sample source:Breast cancer cells | Treatment:DMSO | time point:24 h
F20Sample source:Breast cancer cells | Treatment:DMSO | time point:2 h
F21Sample source:Breast cancer cells | Treatment:DMSO | time point:4 h
F22Sample source:Breast cancer cells | Treatment:DMSO | time point:6 h
Data matrix
  logo